Laxmi Dental Q3 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Laxmi Dental management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Laxmi Dental management said on order book — free account, 30 seconds.
Capex plans
Track Laxmi Dental — get its next earnings analysis in your feed
Margin guidance
Order book
How does Laxmi Dental rank vs peers in Healthcare Equipment & Supplies?
Pro featureHow does Laxmi Dental rank in Healthcare Equipment & Supplies?
Compare Laxmi Dental against every Healthcare Equipment & Supplies company (Q3 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Laxmi Dental's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- QMS Medical (Q1 FY27)
Contract renewals historically exhibit a 60-70% roll-over rate annually, ensuring revenue visibility from existing clients. Key concall takeaways from QMS…
- Tarsons Products (Q2 FY26)
Plastic labware market is expanding faster than glass, currently at INR1,200 crores, signaling long-term sector growth opportunities. Key concall takeaways…
- Vaidya Sane (Q2 FY26)
Ongoing construction and CAPEX of about INR 25-30 crores for capacity expansion at Khopoli and Nagpur hospitals. Key concall takeaways from Vaidya Sane's Q2…
- Tarsons Products (Q3 FY26)
Tarsons has undertaken a significant capex of INR 600 crores announced in 2021-22, with partial commercialization in 2026. Key concall takeaways from Tarsons…